Topol: Well, that gets us to the public trust and the fact that willingness to have the vaccine is important. Because if there is terrible mistrust, we won’t ever get to the level of immunity in the population.
Offit: It’s hard to promote trust now absent data. Once we know the characteristics of these vaccines, it’ll be much easier to try to explain what we know and what we don’t know. Because I really do think it’s going to be a matter of managing expectations.